Dec 31 (Reuters) - Reckitt Benckiser Group PLC :
* US FDA: RECKITT/MEAD JOHNSON NUTRITION VOLUNTARILY RECALLS SELECT BATCHES OF NUTRAMIGEN HYPOALLERGENIC INFANT FORMULA POWDER
* US FDA: RECKITT/MJN VOLUNTARILY'S RECALL FROM U.S. MARKET DUE TO POSSIBILITY OF CONTAMINATION WITH CRONOBACTER SAKAZAKII IN PRODUCT SAMPLED OUTSIDE US
* US FDA: ALL PRODUCT IN QUESTION WENT THROUGH EXTENSIVE TESTING BY MJN AND TESTED NEGATIVE FOR THE BACTERIA
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.